Does CEMIPLIMAB-RWLC Cause Off label use? 68 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 68 reports of Off label use have been filed in association with CEMIPLIMAB-RWLC. This represents 4.4% of all adverse event reports for CEMIPLIMAB-RWLC.
68
Reports of Off label use with CEMIPLIMAB-RWLC
4.4%
of all CEMIPLIMAB-RWLC reports
12
Deaths
12
Hospitalizations
How Dangerous Is Off label use From CEMIPLIMAB-RWLC?
Of the 68 reports, 12 (17.6%) resulted in death, 12 (17.6%) required hospitalization.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CEMIPLIMAB-RWLC. However, 68 reports have been filed with the FAERS database.
What Other Side Effects Does CEMIPLIMAB-RWLC Cause?
Death (128)
Disease progression (101)
Fatigue (71)
Rash (64)
Dyspnoea (55)
Pyrexia (52)
Pruritus (44)
Asthenia (42)
Diarrhoea (42)
Myocarditis (42)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which CEMIPLIMAB-RWLC Alternatives Have Lower Off label use Risk?
CEMIPLIMAB-RWLC vs CENEGERMIN-BKBJ
CEMIPLIMAB-RWLC vs CENOBAMATE
CEMIPLIMAB-RWLC vs CEPHALEXIN
CEMIPLIMAB-RWLC vs CERITINIB
CEMIPLIMAB-RWLC vs CERLIPONASE ALFA